ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2025
Recent emergence of vaccine-derived poliovirus type 2 in Senegal and virus spread to neighboring countries.
Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
24 authors.
Funding
Abstract
objectivesAs we approach the eradication of poliomyelitis, one of the global challenges is to control and interrupt the transmission of the vaccine-derived polioviruses. In Senegal, an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2) of the NIE-JIS-1 emergence group was previously reported from 2020 to 2021.
methodsOur study report a newemergence of cVDPV2 in Senegal from 2023 to 2024, first detected in sewage and later in stool samples from children with acute flaccid paralysis, particularly, in Southeastern Senegal.
resultsAll recent strains from Senegal were genetically linked, and one sequence was linked to the type 2 novel oral polio vaccine. The phylodynamic analysis showed that the 2023-2024 cVDPV2 sequences from Senegal grouped into a monophyletic group with strains from the Republic of Guinea, and belonged to the NIE-ZAS-1 emergence group. Our data also show that the NIE-ZAS-1 virus was introduced to Senegal around 2010 (95% Highest Posterior Density, 2003-2017) and recently spread to the Republic of Guinea and the Republic of Mauritania in 2023 while it continuously circulated in Senegal between 2023 and 2024.
conclusionOur data highlight the importance of strengthening the poliovirus vaccine coverage and surveillance in these countries characterized by frequent population movements. Moreover, more studies on risks associated with VDPV2 mutations to enhance virulence are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.